Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Response to comments on "Measurable residual disease after venetoclax treatment for relapsed or refractory chronic lymphocytic leukemia in Japan".

International journal of hematology·2026

Same author

Modified short-course fludarabine-based conditioning regimen for salvage cord blood transplantation after graft failure.

International journal of hematology·2026

Same author

Extranodal natural killer/T-cell lymphoma: From fatal to curable.

CA: a cancer journal for clinicians·2026

Same author

Impact of the diagnosis-to-treatment interval on the survival of patients with CD5-positive diffuse large B-cell lymphoma.

Annals of hematology·2026

Same author

International Survey for Antiemetics in Hematopoietic Stem Cell Transplantation in the APBMT Centers.

Blood cell therapy·2026

Same author

Advances in the treatment and prognosis of aggressive NK-cell leukemia: results from the ANKL22 study.

Leukemia·2026

Search research articles

Related Experiment Video

Updated: May 1, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

[Extranodal NK/T-cell lymphoma].

Nihon Rinsho. Japanese Journal of Clinical Medicine

|April 15, 2014

Summary

Extranodal NK/T-cell lymphoma (ENKL) treatment has improved significantly with new strategies like chemoradiotherapy and L-Asparaginase regimens. Fragmented Epstein-Barr virus-DNA aids in monitoring tumor burden and treatment response in ENKL patients.

Area of Science:

Hematology
Oncology
Immunology

Context:

Extranodal NK/T-cell lymphoma (ENKL) historically presented a poor prognosis, posing significant treatment challenges.
Recent advancements in therapeutic strategies have markedly improved outcomes for ENKL patients.
Understanding ENKL's unique characteristics is crucial for developing effective treatment protocols.

Purpose:

To review current treatment standards and emerging strategies for extranodal NK/T-cell lymphoma (ENKL).
To highlight the role of novel chemoradiotherapy and L-Asparaginase-based regimens.
To emphasize the prognostic significance of fragmented Epstein-Barr virus-DNA in ENKL management.

Summary:

Simultaneous chemoradiotherapy is the standard for localized nasal ENKL.

More Related Videos

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

Related Experiment Videos

Last Updated: May 1, 2026

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Flow Cytometry-based Assay for the Monitoring of NK Cell Functions

Published on: October 30, 2016

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

An Efficient and Simple Method to Establish NK and T Cell Lines from Patients with Chronic Active Epstein-Barr Virus Infection

Published on: March 30, 2018

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Tumor Engraftment in a Xenograft Mouse Model of Human Mantle Cell Lymphoma

Published on: March 30, 2018

For advanced or relapsed ENKL, L-Asparaginase-containing regimens (SMILE, AspaMetDex) and hematopoietic stem cell transplantation are recommended.

Fragmented Epstein-Barr virus-DNA in blood serves as a valuable biomarker for tumor burden, chemotherapy response, and adverse reactions in ENKL.

Impact:

ENKL is now considered a lymphoma subtype with an intermediate prognosis due to improved treatment strategies.
The integration of biomarkers like EBV-DNA enhances personalized treatment approaches.
Further research is essential to continue refining therapeutic interventions for ENKL.